Sellers of research-chemical peptides frequently point to a "certificate of analysis," or COA, as evidence that their product is pure, safe, or verified. A COA is a real laboratory document, but understanding what it actually tests, and what it doesn't, matters more than whether one exists at all.
What a COA Actually Is
A certificate of analysis is a lab report generated by testing a sample from a specific production batch, typically using a technique like high-performance liquid chromatography (HPLC) or mass spectrometry. In a legitimate pharmaceutical supply chain, COAs are a routine, required part of quality control. In the unregulated research-chemical market, a COA is voluntary, and its value depends entirely on who performed the test and how.
What It Can Tell You
A properly run HPLC or mass spectrometry test can reasonably establish two things: identity, meaning the sample contains the molecule it's labeled as rather than something else entirely, and purity, usually expressed as a percentage representing how much of the sample is the target compound versus synthesis byproducts or other impurities. These are genuinely useful pieces of information as far as they go.
What It Can't Tell You
A standard identity-and-purity COA does not test for sterility, meaning it says nothing about bacterial contamination. It does not test for endotoxins, bacterial byproducts that can cause serious reactions and that have been the specific basis for several documented product recalls covered elsewhere on this site. It also doesn't verify that the tested sample is representative of the actual vial a customer receives, rather than a separate reference sample the seller submitted for testing. A seller can have a real, accurate COA for one batch while shipping product from an entirely different, untested batch under the same listing.
The Lab Matters as Much as the Test
Independent, accredited third-party labs with no financial relationship to the seller carry more weight than in-house testing or testing commissioned from a lab the seller selected without disclosing the relationship. Even then, a COA posted on a website is difficult for a buyer to verify against the actual physical product in hand; there is no simple way for a consumer to confirm that a posted document corresponds to what shipped to them.
Why This Matters Beyond Purity
Because research peptides exist outside the FDA's drug-approval and manufacturing oversight framework, there is no regulatory body routinely auditing these labs, standardizing their testing methods, or verifying their results the way the FDA audits pharmaceutical manufacturing facilities. A COA from this market is closer to a marketing claim one step removed from the seller than it is to the quality assurance behind an FDA-approved drug, even when the underlying lab work is performed honestly.
The Bottom Line
A certificate of analysis is a real document, but it is narrow in scope, hard for a buyer to independently verify, and not a substitute for FDA oversight of manufacturing, sterility, and labeling. Seeing a COA on a product page is not the same as knowing what's actually in the vial that arrives, and it says nothing about whether using an unapproved compound is otherwise safe. Anyone considering a research-use-only product should talk to a doctor about why they're seeking it and whether an approved alternative exists.